Organon Teknika reaches agreement with Anagen
This article was originally published in Clinica
Executive Summary
Following the withdrawal from its marketing agreement with Anagen last year, Organon Teknika has agreed to provide assay stocks, production equipment and instruments at no cost to Anagen. Sales of the instruments are expected to contribute £1 million ($1.5 million) to Anagen's cash reserves in the current year.